This concern comes up regularly, and it is worth addressing directly
The goal is preserving the strength, muscle mass, movement quality, bone health, and resilience that allow women to continue doing the things they love long after the weight loss phase is over
These animal results generated significant excitement and justified moving to human trials
Efe Akademi Yaynlar
Differences among all UA treated groups were analyzed with one-way ANOVA, Tukeys multiple comparisons test on GraphPad Prism 6 software
Patients with severe kidney disease (eGFR below 2030) Patients with recurrent UTIs or fungal infections Type 1 diabetes patients (unless specifically prescribed) Pregnant women References: Protective Influence of SGLT-2 Inhibitors Against Heart Failure PMC 2024 Clinical Evidence for Cardiovascular & Kidney Benefits PMC SGLT2 Inhibitors: Antidiabetic and Cardioprotective Effects PMC Emerging Horizons: SGLT-2 Inhibitors Beyond Diabetes PMC DPP-4 inhibitors, sulfonylureas, TZDs So far we have covered the star players Metformin, GLP-1 agonists, and SGLT2 inhibitors